Postbiotic driven immunomodulation: SCFAs as therapeutic agents in rheumatoid arthritis

Mohammad  Kaveh; Sara Kooti

doi:10.61882/jcbior.4.4.292

Authors

Mohammad Kaveh Student Research committee, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
Sara Kooti Air Pollution and Respiratory Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran https://orcid.org/0000-0001-8153-4239

DOI:

https://doi.org/10.61882/jcbior.4.4.292

Keywords:

Rheumatoid arthritis, Postbiotic, Probiotic, Short-chain fatty acids

Abstract

No Abstact.

References

1. Golpour F, Abbasi-Alaei M, Babaei F, Mirzababaei M, Parvardeh S, Mohammadi G, et al. Short chain fatty acids, a possible treatment option for autoimmune diseases. Biomed Pharmacother. 2023;163:114763. DOI: 10.1016/j.biopha.2023.114763 PMID: 37105078

2. Liu XF, Shao JH, Liao YT, Wang LN, Jia Y, Dong PJ, et al. Regulation of short-chain fatty acids in the immune system. Front Immunol. 2023;14:1186892. DOI: 10.3389/fimmu.2023.1186892 PMID: 37215145

3. Kespohl M, Vachharajani N, Luu M, Harb H, Pautz S, Wolff S, et al. The Microbial Metabolite Butyrate Induces Expression of Th1-Associated Factors in CD4+ T Cells. Front Immunol. 2017;8:1036. DOI: 10.3389/fimmu.2017.01036 PMID: 28894447

4. Hui W, Yu D, Cao Z, Zhao X. Butyrate inhibit collagen-induced arthritis via Treg/IL-10/Th17 axis. Int Immunopharmacol. 2019;68:226-233. DOI: 10.1016/j.intimp.2019.01.018 PMID: 30660077

5. Shin Y, Han S, Kwon J, Ju S, Choi TG, Kang I, et al. Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease. Nutrients. 2023;15(20):4466. DOI: 10.3390/nu15204466 PMID: 37892541

6. Dürholz K, Hofmann J, Iljazovic A, Häger J, Lucas S, Sarter K, et al. Dietary Short-Term Fiber Interventions in Arthritis Patients Increase Systemic SCFA Levels and Regulate Inflammation. Nutrients. 2020;12(10):3207. DOI: 10.3390/nu12103207 PMID: 33092271

7. Niu G, Jian T, Gai Y, Chen J. Microbiota and plant-derived vesicles that serve as therapeutic agents and delivery carriers to regulate metabolic syndrome. Adv Drug Deliv Rev. 2023;196:114774. DOI: 10.1016/j.addr.2023.114774 PMID: 36906231